| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |